MedMJ Conference Merges with Marijuana Investor Summit 2015

In the business world, the word synergy gets thrown around a lot. Synergy is the interaction between two or more elements that, when combined, form something greater than the sum of the individual parts. Synergy is often used to describe when two great companies come together, but in the context of today’s discussion, it describes the partnership between two great conferences.

Marijuana Investor Summit 2015 is a conference aimed at enlightening, entertaining, and educating both investors and entrepreneurs about the ever changing and rapidly expanding marijuana industry. Hosted by CannaFundr and Marijuana Investor News, the event will take place on the week of April 20 in downtown Denver and feature some of the top thought leaders in the industry, such as Alan Brochstein of 420 Investor and Douglas Leighton of Dutchess Capital.

MedMJ is a conference dedicated to the medical marijuana investor, covering relevant topics from healthcare liabilities to ground breaking patient research and development. On March 19, it was announced that MedMJ would merge with Marijuana Investor Summit 2015, making it one of the most comprehensive marijuana business conferences to date.

“When we developed the Summit, we knew that medical marijuana was in need of specific attention,” said CannaFundr CEO and Marijuana Investor Summit co-founder Randy Shipley. “When the team of MedMJ requested to hold their conference during ours, I knew this was the best way to highlight the opportunity available for medicinal investment.”

In an industry where investments are at the mercy of the federal government, medical marijuana has turned into one of the safer avenues of investment. The passage of the “Cromnibus” has helped keep the DEA and Department of Justice from running roughshod of the industry; and if the CARERS act is passed in Congress, it will definitively end the war on medical marijuana. As far as marijuana investment goes, medical marijuana has never been more relevant.

One of the most exciting aspects of the MedMJ merger was the addition of speaker Dr. Sue Sisley. Dr. Sisley was let go from her position at the University of Arizona when university officials didn’t like the “optics” of her research into the therapeutic effects of medical marijuana on veterans suffering from PTSD.

Since her departure, Dr. Sisley has been leading the way in PTSD research and most recently received a sizable grant from the Colorado Board of Health to continue her studies as well as being appointed Director of Medical Plant Science at Heliospectra. She is without a doubt one of the best in her field and will contribute greatly to the body of knowledge at MedMJ and Marijuana Investor Summit 2015.

Marijuana Investor Summit is shaping up to be a game changing conference. The merger with MedMJ has made this conference one of the most comprehensive and inclusive summits of its kind and the best news of all is that tickets are still available.

If you want to get in on the ground floor of the most rapidly expanding industry in the United States, then register for Marijuana Investor Summit 2015 and learn how to join investment with innovation.


This article is a part of the World Cannabis Week series sponsored by World Cannabis Week and Marijuana Investor Summit.

William Sumner is a freelance writer and marijuana journalist located in Panama City, FL. Passionate about writing, William is dedicated to journalistic integrity and providing quality insight on current events. You can follow him on Twitter @W_Sumner.

Related posts